India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

NEW YORK, Jan. 11, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

http://www.reportlinker.com/p0750102/India-In-Vitro-Diagnostics-Market-Outlook-to-2017--Clinical-Chemistry-Genetic-Testing-Haematology-Histology-and-Cytology-Immuno-Chemistry-Infectious-Immunology-and-Microbiology-Culture.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData's new report, "India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" provides key market data on the India In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.

- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the India In Vitro Diagnosticsmarket.

- Key players covered include F. Hoffmann-La Roche Ltd., Transasia Bio-Medicals Ltd., Beckman Coulter, Inc., Siemens Healthcare, Abbott Laboratories, Sysmex Corporation and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the India In Vitro Diagnostics competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 11

2 Introduction 14

2.1 What is This Report About? 14

3 In Vitro Diagnostics In India 15

3.1 In Vitro Diagnostics, Market Segmentation 15

3.2 In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, 2003-2017 16

3.3 In Vitro Diagnostics Market, India, Revenue Mix ($m), 2010 18

3.4 In Vitro Diagnostics Market, India, Category Contribution (%), 2010 19

3.5 In Vitro Diagnostics, India, Company Share (2009-2010) 26

4 Clinical Chemistry In India 28

4.1 Clinical Chemistry, Market Segmentation 28

4.2 Clinical Chemistry Market, India, Revenue Mix ($m), 2010 29

4.3 Clinical Chemistry Market, India, Segment Contribution (%), 2010 30

4.4 Clinical Chemistry Overall Revenue (2003-2017) 31

4.4.1 Clinical Chemisty Analyzers Revenue (2003-2017) 35

4.4.2 Urine Analysis Revenue (2003-2017) 39

4.5 Clinical Chemistry Distribution Share (2009-2010) 43

4.6 Clinical Chemistry, India, Company Share (2009-2010) 44

5 Genetic Testing In India 46

5.1 Genetic Testing, Market Segmentation 46

5.2 Genetic Testing Market, India, Revenue Mix ($m), 2010 47

5.3 Genetic Testing Market, India, Segment Contribution (%), 2010 48

5.4 Genetic Testing Overall Revenue (2003-2017) 49

5.5 Genetic Testing Distribution Share (2009-2010) 53

5.6 Genetic Testing, India, Company Share (2009-2010) 54

6 Haematology In India 56

6.1 Haematology, Market Segmentation 56

6.2 Haematology Market, India, Revenue Mix ($m), 2010 57

6.3 Haematology Market, India, Segment Contribution (%), 2010 58

6.4 Haematology Overall Revenue (2003-2017) 59

6.4.1 Haematology Reagents Revenue (2003-2017) 63

6.4.2 Immunohaematology Revenue (2003-2017) 67

6.4.3 Haemostasis Revenue (2003-2017) 71

6.4.4 Haematology Rapid Tests Revenue (2003-2017) 75

6.4.5 Haematology Cell Counters Revenue (2003-2017) 79

6.5 Haematology Distribution Share (2009-2010) 83

6.6 Haematology, India, Company Share (2009-2010) 84

7 Histology And Cytology In India 86

7.1 Histology And Cytology, Market Segmentation 86

7.2 Histology And Cytology Market, India, Revenue Mix ($m), 2010 87

7.3 Histology And Cytology Market, India, Segment Contribution (%), 2010 88

7.4 Histology And Cytology Overall Revenue (2003-2017) 89

7.5 Histology And Cytology Distribution Share (2009-2010) 93

7.6 Histology And Cytology, India, Company Share (2009-2010) 94

8 Immuno Chemistry In India 96

8.1 Immuno Chemistry Market, India, Revenue Mix ($m), 2010 96

8.2 Immuno Chemistry Market, India, Segment Contribution (%), 2010 97

8.3 Immuno Chemistry Overall Revenue (2003-2017) 98

8.3.1 Disease Specific Immunochemistry Revenue (2003-2017) 102

8.3.2 Drugs of Abuse / Toxicology Revenue (2003-2017) 106

8.3.3 Endocrinology Tests Revenue (2003-2017) 110

8.3.4 Therapeutic Drug Monitoring Revenue (2003-2017) 114

8.3.5 Immunochemistry Analyzers Revenue (2003-2017) 118

8.4 Immuno Chemistry Distribution Share (2009-2010) 122

8.5 Immuno Chemistry, India, Company Share (2009-2010) 123

9 Infectious Immunology In India 125

9.1 Infectious Immunology, Market Segmentation 125

9.2 Infectious Immunology Market, India, Revenue Mix ($m), 2010 126

9.3 Infectious Immunology Market, India, Segment Contribution (%), 2010 127

9.4 Infectious Immunology Overall Revenue (2003-2017) 128

9.5 Infectious Immunology Distribution Share (2009-2010) 132

9.6 Infectious Immunology, India, Company Share (2009-2010) 133

10 Microbiology Culture In India 135

10.1 Microbiology Culture, Market Segmentation 135

10.2 Microbiology Culture Market, India, Revenue Mix ($m), 2010 136

10.3 Microbiology Culture Market, India, Segment Contribution (%), 2010 137

10.4 Microbiology Culture Overall Revenue (2003-2017) 138

10.4.1 Microbiology Analyzers Revenue (2003-2017) 142

10.5 Microbiology Culture Distribution Share (2009-2010) 146

10.6 Microbiology Culture, India, Company Share (2009-2010) 147

11 Overview of Key Companies in India In Vitro Diagnostics Market 149

11.1 F. Hoffmann-La Roche Ltd. 149

11.1.1 Company Overview 149

11.1.2 Share in the India In Vitro Diagnostics Market 149

11.2 Transasia Bio-Medicals Ltd. 150

11.2.1 Company Overview 150

11.2.2 Share in the India In Vitro Diagnostics Market 150

11.3 Beckman Coulter, Inc. 151

11.3.1 Company Overview 151

11.3.2 Share in the India In Vitro Diagnostics Market 151

11.4 Siemens Healthcare 152

11.4.1 Company Overview 152

11.4.2 Share in the India In Vitro Diagnostics Market 152

11.5 Abbott Laboratories 153

11.5.1 Company Overview 153

11.5.2 Share in the India In Vitro Diagnostics Market 153

11.6 Sysmex Corporation 154

11.6.1 Company Overview 154

11.6.2 Share in the India In Vitro Diagnostics Market 154

11.7 Becton, Dickinson and Company 155

11.7.1 Company Overview 155

11.8 Span Diagnostics Ltd. 155

11.8.1 Company Overview 155

11.9 Trivitron Healthcare Pvt Ltd. 155

11.9.1 Company Overview 155

11.10 Ortho-Clinical Diagnostics Inc. 156

11.10.1 Company Overview 156

11.11 bioMerieux S.A. 156

11.11.1 Company Overview 156

11.12 Bio-Rad Laboratories, Inc. 156

11.12.1 Company Overview 156

11.13 Alere Inc. 157

11.13.1 Company Overview 157

11.14 J.Mitra & Co. Pvt Ltd 157

11.14.1 Company Overview 157

11.15 Qiagen N.V. 157

11.15.1 Company Overview 157

11.16 OLYMPUS CORPORATION 158

11.16.1 Company Overview 158

11.17 Phadia AB 158

11.17.1 Company Overview 158

11.18 Tulip Group 158

11.18.1 Company Overview 158

11.19 Danaher Corporation 159

11.19.1 Company Overview 159

11.20 HIMEDIA LABORATORIES. PVT. LTD. 159

11.20.1 Company Overview 159

11.21 Thermo Fisher Scientific Inc. 159

11.21.1 Company Overview 159

11.22 Hologic, Inc. 160

11.22.1 Company Overview 160

11.23 Gen-Probe Incorporated 160

11.23.1 Company Overview 160

11.24 Life Technologies Corporation 161

11.24.1 Company Overview 161

12 In Vitro Diagnostics Market Pipeline Products 162

12.1 Clinical Chemisty Market Pipeline Products 162

12.2 Immuno Chemistry Market Pipeline Products 164

12.3 Haematology Market Pipeline Products 167

12.4 Infectious Immunology Market Pipeline Products 169

12.5 Microbiology Culture Market Pipeline Products 173

12.6 Histology and Cytology Market Pipeline Products 174

12.7 Genetic Testing Market Pipeline Products 175

13 Financial Deals Landscape 179

13.1 Partnerships 179

13.1.1 Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 179

13.1.2 Radient Pharmaceuticals Enters Into Distribution Agreement with Super Religare Laboratories 180

13.1.3 Transasia Enters Into Distribution Agreement with Gen-Probe 181

13.1.4 Transasia Enters Into Distribution Agreement with InTec 182

13.1.5 Transasia Enters Into Distribution Agreement Vircell Microbiologists 183

13.1.6 Vermillion Signs Agreement with Quest Diagnostics 184

13.1.7 Trivitron Enters Into Distribution Agreement with Celerus Diagnostics 185

14 Recent Developments 186

14.1 Strategy And Business Planning 186

14.1.1 Nov 16, 2011: TCG Lifesciences Collaborates With JSW Lifesciences To Strengthen R&D Offerings In Area Of CNS 186

14.1.2 Apr 19, 2011: Nihon Kohden Establishes Sales Subsidiary In India 186

14.2 Government and Public Interest 187

14.2.1 Aug 09, 2011: Lifecare Medical Centre Introduces Blood Test To Diagnose Infectious Diseases In Pregnant Women And Newborns 187

14.3 Product News 188

14.3.1 Apr 25, 2011: Applied Visual Sciences Launches TBDxV TB Diagnostic Aid In India 188

15 Appendix 190

15.1 Definitions of Markets Covered in the Report 191

15.1.1 In Vitro Diagnostics 191

15.2 Research Methodology 202

15.3 Secondary Research 202

15.4 Primary Research 203

15.5 Models 203

15.6 Forecasts 204

15.7 Expert Panels 204

15.8 GlobalData Consulting 204

15.9 Currency Conversion 205

15.10 Contact Us 205

15.11 Disclaimer 205

List of Tables

Table 1: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, 2003-2017 17

Table 2: In Vitro Diagnostics Market, India, Category Contribution (%), 2010 19

Table 3: In Vitro Diagnostics, India, Cross-Category Analysis, 2003-2017 21

Table 4: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 23

Table 5: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 25

Table 6: In Vitro Diagnostics, India, Company Share by Revenue ($m), USD Actual, 2009-2010 27

Table 7: Clinical Chemistry Market, India, Segment Contribution (%), 2010 30

Table 8: Clinical Chemistry, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 32

Table 9: Clinical Chemistry, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 34

Table 10: Clinical Chemisty Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 36

Table 11: Clinical Chemisty Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 38

Table 12: Urine Analysis, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 40

Table 13: Urine Analysis, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 42

Table 14: Clinical Chemistry, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 43

Table 15: Clinical Chemistry, India, Company Share by Revenue ($m), USD Actual 2009-2010 45

Table 16: Genetic Testing Market, India, Segment Contribution (%), 2010 48

Table 17: Genetic Testing, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 50

Table 18: Genetic Testing, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 52

Table 19: Genetic Testing, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 53

Table 20: Genetic Testing, India, Company Share by Revenue ($m), USD Actual 2009-2010 55

Table 21: Haematology Market, India, Segment Contribution (%), 2010 58

Table 22: Haematology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 60

Table 23: Haematology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 62

Table 24: Haematology Reagents, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 64

Table 25: Haematology Reagents, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 66

Table 26: Immunohaematology, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 68

Table 27: Immunohaematology, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 70

Table 28: Haemostasis, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 72

Table 29: Haemostasis, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 74

Table 30: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 76

Table 31: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 78

Table 32: Haematology Cell Counters, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 80

Table 33: Haematology Cell Counters, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 82

Table 34: Haematology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 83

Table 35: Haematology, India, Company Share by Revenue ($m), USD Actual 2009-2010 85

Table 36: Histology And Cytology Market, India, Segment Contribution (%), 2010 88

Table 37: Histology And Cytology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 90

Table 38: Histology And Cytology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 92

Table 39: Histology And Cytology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 93

Table 40: Histology And Cytology, India, Company Share by Revenue ($m), USD Actual 2009-2010 95

Table 41: Immuno Chemistry Market, India, Segment Contribution (%), 2010 97

Table 42: Immuno Chemistry, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 99

Table 43: Immuno Chemistry, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 101

Table 44: Disease Specific Immunochemistry, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 103

Table 45: Disease Specific Immunochemistry, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 105

Table 46: Drugs of Abuse / Toxicology, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 107

Table 47: Drugs of Abuse / Toxicology, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 109

Table 48: Endocrinology Tests, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 111

Table 49: Endocrinology Tests, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 113

Table 50: Therapeutic Drug Monitoring, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 115

Table 51: Therapeutic Drug Monitoring, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 117

Table 52: Immunochemistry Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 119

Table 53: Immunochemistry Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 121

Table 54: Immuno Chemistry, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 122

Table 55: Immuno Chemistry, India, Company Share by Revenue ($m), USD Actual 2009-2010 124

Table 56: Infectious Immunology Market, India, Segment Contribution (%), 2010 127

Table 57: Infectious Immunology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 129

Table 58: Infectious Immunology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 131

Table 59: Infectious Immunology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 132

Table 60: Infectious Immunology, India, Company Share by Revenue ($m), USD Actual 2009-2010 134

Table 61: Microbiology Culture Market, India, Segment Contribution (%), 2010 137

Table 62: Microbiology Culture, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 139

Table 63: Microbiology Culture, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 141

Table 64: Microbiology Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 143

Table 65: Microbiology Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 145

Table 66: Microbiology Culture, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 146

Table 67: Microbiology Culture, India, Company Share by Revenue ($m), USD Actual 2009-2010 148

Table 68: Clinical Chemisty Market Pipeline Products 162

Table 69: Immuno Chemistry Market Pipeline Products 164

Table 70: Haematology Market Pipeline Products 167

Table 71: Infectious Immunology Market Pipeline Products 169

Table 72: Microbiology Culture Market Pipeline Products 173

Table 73: Histology and Cytology Market Pipeline Products 174

Table 74: Genetic Testing Market Pipeline Products 175

Table 75: Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 179

Table 76: Radient Pharmaceuticals Enters Into Distribution Agreement With Super Religare Laboratories 180

Table 77: Transasia Enters Into Distribution Agreement With Gen-Probe 181

Table 78: Transasia Enters Into Distribution Agreement With InTec 182

Table 79: Transasia Enters Into Distribution Agreement Vircell Microbiologists 183

Table 80: Vermillion Signs Agreement With Quest Diagnostics 184

Table 81: Trivitron Enters Into Distribution Agreement With Celerus Diagnostics 185

Table 82: USD to Local Currency, India, Average Actual Rate 2003-2010 205

List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 15

Figure 2: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, 2003-2017 16

Figure 3: In Vitro Diagnostics Market, India, Revenue Mix ($m), 2010 18

Figure 4: In Vitro Diagnostics Market, India, Category Contribution (%), 2010 19

Figure 5: In Vitro Diagnostics, India, Cross-Category Analysis, 2003-2017 20

Figure 6: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22

Figure 7: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24

Figure 8: In Vitro Diagnostics, India, Company Share (%), 2010 26

Figure 9: Clinical Chemistry, Market Segmentation 28

Figure 10: Clinical Chemistry Market, India, Revenue Mix ($m), 2010 29

Figure 11: Clinical Chemistry Market, India, Segment Contribution (%), 2010 30

Figure 12: Clinical Chemistry, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 31

Figure 13: Clinical Chemistry, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 33

Figure 14: Clinical Chemisty Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 35

Figure 15: Clinical Chemisty Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 37

Figure 16: Urine Analysis, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 39

Figure 17: Urine Analysis, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 41

Figure 18: Clinical Chemistry, India, Company Share (%), 2010 44

Figure 19: Genetic Testing, Market Segmentation 46

Figure 20: Genetic Testing Market, India, Revenue Mix ($m), 2010 47

Figure 21: Genetic Testing Market, India, Segment Contribution (%), 2010 48

Figure 22: Genetic Testing, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 49

Figure 23: Genetic Testing, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 51

Figure 24: Genetic Testing, India, Company Share (%), 2010 54

Figure 25: Haematology, Market Segmentation 56

Figure 26: Haematology Market, India, Revenue Mix ($m), 2010 57

Figure 27: Haematology Market, India, Segment Contribution (%), 2010 58

Figure 28: Haematology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 59

Figure 29: Haematology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 61

Figure 30: Haematology Reagents, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 63

Figure 31: Haematology Reagents, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 65

Figure 32: Immunohaematology, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 67

Figure 33: Immunohaematology, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 69

Figure 34: Haemostasis, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 71

Figure 35: Haemostasis, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 73

Figure 36: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 75

Figure 37: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 77

Figure 38: Haematology Cell Counters, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 79

Figure 39: Haematology Cell Counters, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 81

Figure 40: Haematology, India, Company Share (%), 2010 84

Figure 41: Histology and Cytology, Market Segmentation 86

Figure 42: Histology And Cytology Market, India, Revenue Mix ($m), 2010 87

Figure 43: Histology And Cytology Market, India, Segment Contribution (%), 2010 88

Figure 44: Histology And Cytology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 89

Figure 45: Histology And Cytology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 91

Figure 46: Histology And Cytology, India, Company Share (%), 2010 94

Figure 47: Immuno Chemistry Market, India, Revenue Mix ($m), 2010 96

Figure 48: Immuno Chemistry Market, India, Segment Contribution (%), 2010 97

Figure 49: Immuno Chemistry, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 98

Figure 50: Immuno Chemistry, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 100

Figure 51: Disease Specific Immunochemistry, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 102

Figure 52: Disease Specific Immunochemistry, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 104

Figure 53: Drugs of Abuse / Toxicology, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 106

Figure 54: Drugs of Abuse / Toxicology, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 108

Figure 55: Endocrinology Tests, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 110

Figure 56: Endocrinology Tests, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 112

Figure 57: Therapeutic Drug Monitoring, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 114

Figure 58: Therapeutic Drug Monitoring, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 116

Figure 59: Immunochemistry Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 118

Figure 60: Immunochemistry Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 120

Figure 61: Immuno Chemistry, India, Company Share (%), 2010 123

Figure 62: Infectious Immunology, Market Segmentation 125

Figure 63: Infectious Immunology Market, India, Revenue Mix ($m), 2010 126

Figure 64: Infectious Immunology Market, India, Segment Contribution (%), 2010 127

Figure 65: Infectious Immunology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 128

Figure 66: Infectious Immunology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 130

Figure 67: Infectious Immunology, India, Company Share (%), 2010 133

Figure 68: Microbiology Culture, Market Segmentation 135

Figure 69: Microbiology Culture Market, India, Revenue Mix ($m), 2010 136

Figure 70: Microbiology Culture Market, India, Segment Contribution (%), 2010 137

Figure 71: Microbiology Culture, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 138

Figure 72: Microbiology Culture, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 140

Figure 73: Microbiology Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 142

Figure 74: Microbiology Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 144

Figure 75: Microbiology Culture, India, Company Share (%), 2010 147

Figure 76: F. Hoffmann-La Roche Ltd., Company Share (%),India In Vitro Diagnostics Market, 2010 149

Figure 77: Transasia Bio-Medicals Ltd., Company Share (%), India In Vitro Diagnostics Market, 2010 150

Figure 78: Beckman Coulter, Inc., Company Share (%),India In Vitro Diagnostics Market, 2010 151

Figure 79: Siemens Healthcare, Company Share (%),India In Vitro Diagnostics Market, 2010 152

Figure 80: Abbott Laboratories, Company Share (%),India In Vitro Diagnostics Market, 2010 153

Figure 81: Sysmex Corporation, Company Share (%),India In Vitro Diagnostics Market, 2010 154

Companies mentioned

F. Hoffmann-La Roche Ltd.

Transasia Bio-Medicals Ltd.

Beckman Coulter, Inc.

Siemens Healthcare

Abbott Laboratories

Sysmex Corporation

Becton, Dickinson and Company

Span Diagnostics Ltd.

Trivitron Healthcare Pvt Ltd.

Ortho-Clinical Diagnostics Inc.

bioMerieux S.A.

Bio-Rad Laboratories, Inc.

Alere Inc.

J.Mitra & Co. Pvt Ltd

Qiagen N.V.

OLYMPUS CORPORATION

Phadia AB

Tulip Group

Danaher Corporation

HIMEDIA LABORATORIES. PVT. LTD.

Thermo Fisher Scientific Inc.

Hologic, Inc.

Gen-Probe Incorporated

Life Technologies Corporation

To order this report:

In Vitro Diagnostic Industry: India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker